Navigation Links
STERRAD(R) CYCLESURE(R) Biological Indicator is now 24 Hours, Accelerating Instrument Throughput
Date:1/12/2009

IRVINE, Calif., Jan. 12 /PRNewswire/ -- Advanced Sterilization Products (ASP) is pleased to announce that its STERRAD(R) CYCLESURE(R) Biological Indicator readout time has significantly improved from a 48 hour incubation time to only 24 hours. Now, STERRAD(R) System customers can safely record biological indicator results in 50% less time, speeding up instrument throughput in the sterilization department. The product name is also changing to STERRAD(R) CYCLESURE(R) 24 Biological Indicator to reflect this time-saving improvement.

ASP successfully re-engineered the product after receiving feedback from customers requesting a faster incubation period. A faster incubation period keeps sterilization departments moving efficiently as well as limiting the need to purchase duplicate instrument inventories, which is frequently required when waiting for the results of a 48 hour or more biological indicator readout.

"ASP has been providing healthcare organizations with STERRAD(R) System technology and supplies for almost two decades," says Karen Borg, Worldwide Vice President of Marketing for ASP. "We are committed to continuous product innovation and are passionate about designing and marketing infection prevention solutions like the STERRAD(R) CYCLESURE(R) 24 Biological Indicator that not only meet our customers' needs, but often exceed them."

The STERRAD(R) CYCLESURE(R) 24 Biological Indicator can be used with all of ASP's market-leading, low-temperature hydrogen peroxide gas plasma STERRAD(R) Systems: the STERRAD(R) 100NX(TM) System, STERRAD(R) NX(TM) System, STERRAD(R) 100S System, STERRAD(R) 200 System, as well as the STERRAD(R) 50 System. The STERRAD(R) CYCLESURE(R) 24 Biological Indicator is only validated for use in STERRAD(R) Systems.

For information about STERRAD(R) System products, ASP or ASP's line of infection prevention solutions, visit www.sterrad.com or call 1-888-STERRAD.

About ASP

Advanced Sterilization Products (ASP), division of Ethicon, Inc., a Johnson & Johnson company, has a long track record of designing and delivering innovative infection prevention solutions that dramatically raise the level of health and safety for those who matter most. Our pioneering technology, global distribution, and established leadership position enable us to simplify the process of buying and operating infection prevention products and services every day, for thousands of medical facilities around the world. This in turn enables our customers to focus on what they do best - preventing infection and saving lives.

www.sterrad.com

    For Information Contact:

    Scott Shadiow                              Katie Sweet
    Dorland Global Public Relations            ASP
    415-262-5206 (office)                      949-789-3945 (office)
    sshadiow@dorland.com                       ksweet@its.jnj.com


'/>"/>
SOURCE Advanced Sterilization Products
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ASP Launches STERRAD(R) Sterility Guide - Eliminating Paperwork and Ensuring Compliance
2. Thomson Scientific Announces BONDplus for Biological Researchers
3. Neurobiological Technologies Reports Going Concern Qualification
4. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
5. Study questions assumptions about human sensitivity to biological motion
6. Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
7. Neurobiological Technologies Announces Compliance With Nasdaq Listing Standards
8. Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
9. Biological markers of prostate cancer shed light on cancer burden faced by African-American men
10. Sanofi Pasteur Enters Agreement With Crucell for Next-Generation Biologicals Against Rabies
11. Biological Link Between BRCA1 and Breast Cancer Detailed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... 2016 , ... Global Lyme Alliance (GLA), a leading nonprofit ... has named Scott Santarella as its new CEO. , Santarella is former ... San Francisco, where he successfully helped to grow the organization from a regional ...
(Date:5/24/2016)... ... May 24, 2016 , ... Researchers ... of protocols designed to reduce bleeding complications from percutaneous coronary intervention (PCI). The ... Interventions (SCAI) in Orlando, FL, document a 40% reduction in risk-adjusted bleeding event ...
(Date:5/24/2016)... ... May 24, 2016 , ... Design Concepts ... ‘El Centro del Quinto Sol Wheel Park’ in Pueblo, Colorado. This park was ... offer something special for this often overlooked neighborhood. Located at 609 E. 6th ...
(Date:5/24/2016)... ... May 24, 2016 , ... Celebration is in ... kicked off its 5th Annual Photo Contest. The label contest is underway, and ... year's prizes include a GoPro Hero4, a 40-inch high-definition flat-screen television, an Apple ...
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... On the ... took the time to summarize the weight loss process: , New patients have a ... Composition Analysis (BCA) to get accurately evaluated. , Body Composition Analysis, There are 15 ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... 23, 2016 Experts from various ... Medicine and the role of technology in innovative ... The First International Conference of VPS-Penn Medicine opened in ... and presence of Sheikh Nahyan bin Mubarak Al Nahyan, Minister ... Medicine, which helps provide personalized medicine and tailor-made healthcare in ...
(Date:5/23/2016)... , May 23, 2016 The ... USD 5.0 billion by 2022, according to a new ... of medical waste coupled with the lack of centralized ... expected to drive the demand for reprocessed medical devices ... as compared to that of the original device is ...
(Date:5/22/2016)... DUBLIN , May 23, 2016 ... to develop its anti-fibrotic and anti-inflammatory compound DS102 ... well as in non-alcoholic steatohepatitis (NASH) patients. ... is significantly sequestered in lung tissue and has ... tissue after oral administration. The Company will publish ...
Breaking Medicine Technology: